Stockholm - Delayed Quote SEK
Diagonal Bio AB (publ) (DIABIO.ST)
0.0145
0.0000
(0.00%)
At close: March 18 at 5:09:21 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
248
62
23
203
407
Cost of Revenue
-781
-880
-3,110
-1,851
492
Gross Profit
1,029
942
3,133
2,054
-85
Operating Expense
10,252
10,363
14,700
17,217
11,578
Operating Income
-9,223
-9,421
-11,567
-15,163
-11,663
Net Non Operating Interest Income Expense
-247
-509
-112
-1,001
0
Pretax Income
-9,470
-9,930
-11,678
-16,164
-11,663
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-9,470
-9,930
-11,678
-16,164
-11,663
Diluted NI Available to Com Stockholders
-9,470
-9,930
-11,678
-16,164
-11,663
Basic EPS
0.03
-0.04
-0.32
-1.70
-1.70
Diluted EPS
0.03
-0.04
-0.32
-1.70
-1.70
Basic Average Shares
455,906.6680
275,508.4900
36,478.4910
9,499.5790
6,876.3320
Diluted Average Shares
455,906.6680
275,508.4900
36,478.4910
9,499.5790
6,876.3320
Total Operating Income as Reported
-9,223
-9,421
-11,566
-15,163
-11,663
Total Expenses
9,471
9,483
11,590
15,366
12,070
Net Income from Continuing & Discontinued Operation
-9,470
-9,930
-11,678
-16,164
-11,663
Normalized Income
-9,470
-9,930
-11,678
-16,164
-11,663
Interest Income
75
75
94
0
0
Interest Expense
322
584
206
1,001
0
Net Interest Income
-247
-509
-112
-1,001
0
EBIT
-9,148
-9,346
-11,472
-15,163
-11,663
EBITDA
-7,842
-8,335
-11,469
-15,163
-11,663
Reconciled Cost of Revenue
-781
-880
-3,110
-1,851
492
Reconciled Depreciation
1,306
1,011
3
0
--
Net Income from Continuing Operation Net Minority Interest
-9,470
-9,930
-11,678
-16,164
-11,663
Normalized EBITDA
-7,842
-8,335
-11,469
-15,163
-11,663
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/24/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade